Back
Fairfax India Holdings Vs. Xtacy Therapeutics Industry Stock Comparison
Buy
65
FIH.U.TO
Fairfax India Holdings
Last Price:
15.00
Seasonality Move:
5.36%
Sell
20
XTCY.CX
Xtacy Therapeutics
Last Price:
0.02
Seasonality Move:
43.46%
Buy
65
Fairfax India Holdings (FIH.U.TO)
is a Buy
Is Fairfax India Holdings a Buy, Sell or Hold?
- The current Fairfax India Holdings [FIH.U.TO] share price is $14.76. The Score for FIH.U.TO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- FIH.U.TO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Xtacy Therapeutics (XTCY.CX)
is a Sell
Is Xtacy Therapeutics a Buy, Sell or Hold?
- The current Xtacy Therapeutics [XTCY.CX] share price is $0.02. The Score for XTCY.CX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- XTCY.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FIH.U.TO Stock Price Chart
What is Fairfax India Holdings's stock price today?
-
The Fairfax India Holdings share price today is $14.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FIH.U.TO is experiencing selling pressure, which indicates risk of future bearish movement.
XTCY.CX Stock Price Chart
What is Xtacy Therapeutics's stock price today?
-
The Xtacy Therapeutics share price today is $0.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing slight buying pressure.
FIH.U.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.13 | Buy |
Relative Strength Index (14 RSI): | 55.79 | Buy |
Chaikin Money Flow: | -23947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.31 - 14.73) | Buy |
Bollinger Bands (100): | (14.03 - 14.63) | Buy |
XTCY.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 38.74 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.02 - 0.04) | Sell |
Bollinger Bands (100): | (0.03 - 0.05) | Sell |
FIH.U.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.75 | Buy |
20-day SMA: | 14.56 | Buy |
50-day SMA: | 14.41 | Buy |
200-day SMA: | 14.48 | Buy |
8-day EMA: | 14.77 | Sell |
20-day EMA: | 14.62 | Buy |
50-day EMA: | 14.48 | Buy |
200-day EMA: | 14.25 | Buy |
XTCY.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.03 | Sell |
20-day SMA: | 0.03 | Sell |
50-day SMA: | 0.04 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.03 | Sell |
20-day EMA: | 0.03 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.05 | Sell |
Fairfax India Holdings Earnings Growth & FIH.U.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fairfax India Holdings Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Xtacy Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |